$32.80
-0.61 (-1.83%)
Open$33.56
Previous Close$33.41
Day High$34.41
Day Low$32.35
52W High$34.41
52W Low$16.00
Volume—
Avg Volume329.6K
Market Cap2.29B
P/E Ratio—
EPS$-2.75
SectorPharmaceuticals
Analyst Ratings
Strong Buy
20 analysts
Price Target
-31.7% upside
Current
$32.80
$32.80
Target
$22.40
$22.40
$12.72
$22.40 avg
$29.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 601.07M | 622.81M | 541.11M |
| Net Income | 107.25M | 120.49M | 94.92M |
| Profit Margin | 17.8% | 19.4% | 17.5% |
| EBITDA | 198.86M | 206.18M | 175.68M |
| Free Cash Flow | 71.76M | 51.92M | 65.95M |
| Rev Growth | +10.0% | +14.9% | +24.5% |
| Debt/Equity | 0.21 | 0.20 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |